Biocryst stock news
WebApr 6, 2024 · SA News Fri, Mar. 18, 2024 3 Comments BioCryst executive sells 20K company shares in first insider selling since May 2024 SA News Thu, Mar. 10, 2024 12 Comments WebFeb 23, 2024 · BioCryst (BCRX) delivered earnings and revenue surprises of -29.03% and 2.11%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Biocryst stock news
Did you know?
WebThe 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price … WebSep 13, 2024 · BioCryst has beat first- and second-quarter Wall Street sales estimates by more than 75%. There is currently a short position of 20-plus million shares in a stock that has an average daily trading ...
WebApr 6, 2024 · BioCryst Pharmaceuticals, Inc. (BioCryst) is a commercial-stage biotechnology company that discovers small-molecule medicines. The Company focus on oral treatments for rare diseases in which unmet medical needs exist and an enzyme plays the key role in the biological pathway of the disease. ORLADEYO (berotralstat) is an … WebApr 12, 2024 · April 12, 2024 - 7:00 am. RESEARCH TRIANGLE PARK, N.C., April 12, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today …
WebApr 6, 2024 · Financial Performance. In 2024, BCRX's revenue was $270.83 million, an increase of 72.31% compared to the previous year's $157.17 million. Losses were -$247.12 million, 34.3% more than in 2024. Financial Statements. WebApr 6, 2024 · A high-level overview of BioCryst Pharmaceuticals, Inc. (BCRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …
WebApr 14, 2024 · In other BioCryst Pharmaceuticals news, CEO Jon P. Stonehouse sold 100,000 shares of BioCryst Pharmaceuticals stock in a transaction that occurred on Wednesday, February 1st. The shares were sold ...
WebApr 8, 2024 · RBC Capital analyst Brian Abrahams maintained a Hold rating on BioCryst ( BCRX – Research Report) on April 6 and set a price target of $9.00. The company’s shares closed last Thursday at $8.68 ... east beamer adult shelter woodland caWebFind the latest news headlines from BioCryst Pharmaceuticals, Inc. Common Stock (BCRX) at Nasdaq.com. BioCryst Pharmaceuticals, Inc. Common Stock (BCRX) News … east beancross farmWebView the latest BioCryst Pharmaceuticals Inc. (BCRX) stock price, news, historical charts, analyst ratings and financial information from WSJ. east beam filter waterWebApr 8, 2024 · RBC Capital analyst Brian Abrahams maintained a Hold rating on BioCryst ( BCRX – Research Report) on April 6 and set a price target of $9.00. The company’s … cuban food minneapolisWebApr 14, 2024 · In other BioCryst Pharmaceuticals news, CEO Jon P. Stonehouse sold 100,000 shares of BioCryst Pharmaceuticals stock in a transaction that occurred on … east bear grass rd longs sc 29568WebBased on 8 Wall Street analysts offering 12 month price targets for BioCryst in the last 3 months. The average price target is $15.25 with a high forecast of $30.00 and a low forecast of $8.00 . The average price target represents a 75.69% change from the last price of $8.68 . cuban food lawrenceville gaWebNov 22, 2024 · Royalty Pharma also has extended its relationship with BioCryst through a $50 million equity investment at a price of $13.00 per share, the volume-weighted average price of BioCryst common stock ... east bear creek san luis